FDA — authorised 16 November 2001
- Status: approved
🇺🇸 Valecoxib in United States
FDA authorised Valecoxib on 16 November 2001
Marketing authorisations
FDA — authorised 16 November 2001
- Application: NDA021341
- Marketing authorisation holder: GD SEARLE
- Local brand name: BEXTRA
- Indication: TABLET — ORAL
- Status: approved
Valecoxib in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Valecoxib approved in United States?
Yes. FDA authorised it on 16 November 2001; FDA authorised it on 16 November 2001.
Who is the marketing authorisation holder for Valecoxib in United States?
Marketing authorisation holder not available in our data.